WHO GMP Certification M. Mitra CDSCO(NZ) - PowerPoint PPT Presentation

About This Presentation
Title:

WHO GMP Certification M. Mitra CDSCO(NZ)

Description:

WHO GMP Certification Scheme M. Mitra Former Dy. Drugs Controller (I), CDSCO, HQ, New Delhi * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Chennai ... – PowerPoint PPT presentation

Number of Views:436
Avg rating:3.0/5.0
Slides: 45
Provided by: Malay3
Category:

less

Transcript and Presenter's Notes

Title: WHO GMP Certification M. Mitra CDSCO(NZ)


1
WHO GMP Certification Scheme
M.
Mitra Former Dy. Drugs Controller (I), CDSCO, HQ,
New Delhi
2
WHO GMP CERTIFICATION
  • Originally promugulated in 1969 and revised in
    1975. Main objectives were
  • Guidelines be developed for official inspections
    of dug manufacturing facilities
  • To assess compliance of GMP
  • This would facilitate implementation of the
    scheme

3
WHO GMP CERTIFICATION
  • With 191 countries members in the scheme a
    solution was found for international commerce
    between these countries. The scheme offered a
    solution for those countries which did not have a
    developed regulatory agency yet wanted to import
    drugs.

4
(No Transcript)
5
WHO GMP CERTIFICATION
  • Basic principles of WHO Good Manufacturing
    Practice is similar to any established GMP
    requirement. Allied documents like Schedule M,
    CFRs, ASEAN GMP, etc are all similar in nature.
    Anyone following any established GMP procedure
    will automatically understand the principles in
    the other GMP requirements.

6
WHO GMP CERTIFICATION
  • WHO GMP requirements have been developed taking
    into account the principles in various GMP texts
    and also considering the requirements of
    developing countries. These requirements are not
    for domestic use but for international trade.

7
WHO GMP CERTIFICATION
  • There are around 1000 (?) WHO GMP certified
    manufacturing establishments in the country, with
    West Zone leading followed by the South, North
    and the East Zones.
  • New Applications are coming in everyday due to
    increase in exports of drugs, India being a major
    exporter of Drugs Pharmaceuticals Globally.
  • Other purchasers like the State governments, ESI
    etc. have also started (erroneously) asking for
    the certificates as preconditions.

8
WHO GMP CERTIFICATION
  • WHO GMP ensures the following
  • Avoidance of Cross- Contamination
  • Prevention of Mix-ups
  • Provide Traceability
  • Accountability of actions
  • Responsibility
  • Product Performance Guarantee

9
WHO GMP CERTIFICATION
  • Understanding WHO GMP
  • Documents and Literature

10
WHO GMP CERTIFICATION
  • A series of reports known as the WHO
    Technical Report Series (TRS) are available.
  • TRS 823 (1992)
  • TRS 834 (1993)
  • TRS 863 (1996)
  • TRS 885 (1999)
  • TRS 902 (2002)
  • TRS 908 (2003)
  • TRS 917 (2004)
  • TRS 929 (2005)
  • TRS 937 (2006)

11
WHO GMP CERTIFICATION
  • Other documents
  • A WHO Guide to Good Manufacturing Practice
    (GMP) Requirements (WHO/VSQ/97.02) (for
    validation)

12
(No Transcript)
13
WHO GMP CERTIFICATION
  • Various other documents are available with WHO
    which is freely available for users. WHO website
    is the best source for getting information.
    Similarly documents of other established
    Regulatory agencies can expand knowledge and
    understanding

14
WHO GMP CERTIFICATION
  • Issue of Certificates
  • What are the Certificates?
  • Three types of Certificates are recommended by
    the WHO.
  • These are
  • Product Certificate (COPP) (TRS 823, 863)
  • Statement of Licensing Status (TRS 823, 863)
  • Batch Certificate (TRS
    823, 863)
  • There is another Certificate Site Certificate.
    Described later

15
WHO GMP CERTIFICATION
  • The member state shall attest the following
    conditions of a manufacturer if required to
    attest a product for the certification
  • A specific product is authorized to be placed in
    the market of the exporting country, if not why
    not
  • The manufacturing plant is subject to regular
    inspections for WHO GMP compliance
  • All product information, including labeling is
    currently authorized in the certifying country.

16
WHO GMP CERTIFICATION
  • Conditions to be satisfied before opting for the
    scheme by any member country
  • Effective national licensing system for products,
    manufacturers and distributor
  • Effective control of quality of products,
    including independent laboratory
  • A technically competent, experienced, resourceful
    National Pharmaceutical inspectorate, as part of
    NDRA having legal powers for investigations
  • Administrative capacity to issue Certificates and
    quickly notify WHO and other member countries

17
WHO GMP CERTIFICATION
  • Understanding the Technical Report Series
  • TRS 823 Salient features
  • PART I Quality Management in the Drug Industry
    Philosophy Essential Elements
  • Quality Assurance
  • Good Manufacturing Practice
  • Quality Control
  • Sanitation Hygiene
  • Validation
  • Complaints

18
WHO GMP CERTIFICATION
  • PART I contd.
  • Product recalls
  • Contract Production Analysis
  • Self-inspection and quality audits
  • Personnel (including key personnel)
  • Equipment
  • Premises
  • Material
  • Documentation

19
WHO GMP CERTIFICATION
  • PART II Good Practices Production Quality
    Control
  • Good Practices in Production
  • Includes General requirements, prevention of
    cross contamination and bacterial contamination,
    processing operations, packaging operations
  • Good Practices in Quality Control
  • Control of starting material and intermediate,
    bulk, and finished products, test requirements,
    production record review, stability studies

20
WHO GMP CERTIFICATION
  • PART III Supporting and Supplementary Guidelines
  • Sterile pharmaceutical Products
  • General requirements (air classifications),
    manufacture of sterile preps, personnel,
    premises, equipment, sanitation, processing,
    sterilization, filtration, finishing, quality
    control,
  • Good Manufacturing Practice for Active
    Pharmaceutical Ingredients
  • Explanation, general considerations, personnel,
    premises, equipment, sanitation, documentation,
    retention of records and ref samples, production,
  • Form and content of inspectors report
  • Validation of analytical procedures
  • A Model Certificate Format is also presented

21
WHO GMP CERTIFICATION
  • TRS 863 Salient features
  • Useful guidelines
  • Guidelines for Stability Testing
  • Guidelines for Validation
  • Import Procedure for Drugs
  • Guidelines for implementation of the Scheme
    (including model certificate)
  • Guidelines on import procedures for
    pharmaceutical products

22
WHO GMP CERTIFICATION
  • TRS 885 Salient features
  • GMP Authorised Persons - Role, Functions
    Training
  • Role and position of authorized person,
    implementation of the quality system, education
    and training., routine duties of an authorized
    person,
  • GMP Supplementary Guidelines for the
    Manufacture of Pharmaceutical Excepient
  • General considerations, self inspection and
    quality audits, use of equipment, cleaning
    programme, starting material, rejected and
    recovered materials, returned excepients, storage
    practices, specifications, BPRs, change control
    and process validation, prevention of cross
    contamination, blending, microbial contamination,
    water systems, packaging, quality control etc.

23
WHO GMP CERTIFICATION
  • TRS 902 Salient features
  • Good Practices for National Control
    Laboratories
  • Basic elements of GMP (definition)
  • GMP for Sterile Products revision
  • Inspections
  • National GMP Inspectorate
  • Guidelines on Packaging of Pharmaceutical
    Products
  • Storage areas
  • Labels

24
WHO GMP CERTIFICATION
  • TRS 908 Salient features
  • GMP for radio pharmaceuticals
  • GMP for Pharmaceutical Products
  • Main principles
  • HACCP
  • Guidance on GMP Inspection report
  • Guide to good storage practices for
    pharmaceuticals
  • Model Certificate of a Pharmaceutical Product
  • Site Certificate does not replace the Product
    certificate

25
WHO GMP CERTIFICATION
  • TRS 917 Salient features
  • Active Pharmaceutical Ingredients API
  • Herbal

26
TRS 929 Salient features
  • Concept of sampling of starting materials
  • Heating ventilation and air conditioning
  • Validation
  • Water for pharmaceutical use

  • ..\GMP matters\WHO_TRS_929.pdf

27
TRS 937 Salient features
  • One of the most important TRS
  • Supplementary guidelines on GMP for HVAC
  • (Supplementary guidelines on GMP for Herbals)
  • Supplementary guidelines on GMP Validation
  • HVAC Water Systems
  • Cleaning
  • Analytical Method
  • Computerized Systems
  • Qualification of systems and equipment
  • Non-sterile process validation
  • Good Distribution Practices for pharmaceutical
    products

28
WHO GMP CERTIFICATION
  • How to Certify a Product
  • Certification of products are done after
    thorough examination of the product and the
    facilities where these are manufactured

29
WHO GMP CERTIFICATION
  • How to Certify a Product
  • The facilities are Inspected NRA Inspectors with
    good knowledge of GMP
  • The inspection may take two or more days
  • Certificates are issued by the Issuing Authority
    on the recommendation of the joint report

30
WHO GMP CERTIFICATION
  • Requirements
  • Procedures Main Requirements
  • Product
  • Procedures
  • Facilities

31
WHO GMP CERTIFICATION
  • Requirements
  • Product
  • The basic requirements of the product are
  • Product design
  • Stability Studies
  • Process validation

32
WHO GMP CERTIFICATION
  • Requirements
  • Procedures
  • All actions taken in the facility which leads
    to the production of the final product as per
    specification.

33
WHO GMP CERTIFICATION
  • Requirements
  • Facilities
  • This encompasses the building, machinery,
    services and utilities, manpower etc. These are
    guided towards making a properly designed product.

34
(No Transcript)
35
(No Transcript)
36
(No Transcript)
37
WHO GMP CERTIFICATION
  • Inspection Points
  • 1. Quality Management
  • 2. Sanitation and hygiene
  • 3. Validation
  • 4. Complaints and recalls
  • 5. Contract production and analysis
  • 6. Self Inspection
  • 7. Personnel

38
WHO GMP CERTIFICATION
  • Discussions
  • 8. Premises
  • 9. Equipment
  • 10. Materials
  • 11. Documentation
  • 12. Sterile production
  • 13. Active pharmaceutical ingredients

39
WHO GMP CERTIFICATION
  • GMP consists of various activities which an be
    grouped together as follows
  • Training - induction, ongoing, refresher
    etc.alonwith such documents like SOP,
    training calendar, assessment
    etc.
  • Cleaning sanitation and hygiene - may also
    include workers entry
    procedure, cleaning of the
    premises etc
  • Validation and calibration - qualification of
    machinery,
    equipment etc.
  • Storage - apart from normal ware-housing
    facilities, this should also
    address quarantine, procedure Etc.

40
WHO GMP CERTIFICATION
  1. movement of manpower, material - uni-flow
    movement,
    movements control etc.
  2. Quality assurance
  3. Quality control
  4. Documentation - must include MFR, BPR, SOP
    Documents control
    distribution, cleaning, training, and
    document regulating and
    recording other
    activities
  5. Change control
  6. Self inspections and audits

41
WHO GMP CERTIFICATION
  • Usual Problems faced by Regulatory Agencies
  • Fund problems
  • Lack of knowledge on the part of applicants
  • Lethargic mindset
  • Back to original condition after Certification
  • Usual Problems faced by applicants
  • Sometimes lack of Knowledge on the part of
    auditors
  • Teacher as well as Examiner status
  • Lack of time for thorough auditing

42
WHO GMP CERTIFICATION
  • Useful Web Sites
  • http//www.who.int/en/
  • http//www.who.int/bookorders/anglais/
  • subscription1.jsp?sesslan1
  • http//www.who.int/medicines/organization/
  • qsm/activities/qualityassurance/gmp/gm
    pcover.html
  • http//www.fda.gov/
  • http//www.health.gov.au/tga/docs/html/gmphome.htm
  • http//www.mca.gov.uk/

43
WHO GMP CERTIFICATION
  • M. Mitra
  • Former Dy. Drugs Controller (India),
  • CDSCO
  • (M) 9716755102
  • Email gmpro_at_rediffmail.com

44
Thank you
Write a Comment
User Comments (0)
About PowerShow.com